Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide for Symptom Clusters in Advanced Cancer
NCT00379353Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Sep 2006
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in cancer, sponsored by University of Texas MD Anderson Cancer Center. Started Sep 2006; status: completed.
02
Drugs
thalidomide
03
Conditions
cancer
Beyond the preview
Go deeper on NCT00379353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00379353.